APP and Alzheimer disease: Currently, soluble β-amyloid precursor protein (APP), Aβ, tau and p-tau in cerebrospinal fluid and blood are candidate biomarkers for AD (Hampel et al., 2010; Shekhar et al., 2016; Lucey et al., 2017; Tatebe et al., 2017).